A Study of Prexasertib (LY2606368) in Participants With Advanced Cancer

Clinical trial NCT02778126 · COMPLETED

Trial details

NCT number: NCT02778126
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2016-09-22
Primary completion: 2017-04-29
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.